302 related articles for article (PubMed ID: 23524982)
1. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs.
Evans BC; Nelson CE; Yu SS; Beavers KR; Kim AJ; Li H; Nelson HM; Giorgio TD; Duvall CL
J Vis Exp; 2013 Mar; (73):e50166. PubMed ID: 23524982
[TBL] [Abstract][Full Text] [Related]
2. The efficiency of cytosolic drug delivery using pH-responsive endosomolytic polymers does not correlate with activation of the NLRP3 inflammasome.
Baljon JJ; Dandy A; Wang-Bishop L; Wehbe M; Jacobson ME; Wilson JT
Biomater Sci; 2019 Apr; 7(5):1888-1897. PubMed ID: 30843539
[TBL] [Abstract][Full Text] [Related]
3. The design and synthesis of polymers for eukaryotic membrane disruption.
Murthy N; Robichaud JR; Tirrell DA; Stayton PS; Hoffman AS
J Control Release; 1999 Aug; 61(1-2):137-43. PubMed ID: 10469910
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of intracellular trafficking, cytosolic bioavailability, and target manipulation of an antibody delivery platform.
Lv W; Champion JA
Nanomedicine; 2021 Feb; 32():102315. PubMed ID: 33065253
[TBL] [Abstract][Full Text] [Related]
5. Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.
El-Sayed A; Futaki S; Harashima H
AAPS J; 2009 Mar; 11(1):13-22. PubMed ID: 19125334
[TBL] [Abstract][Full Text] [Related]
6. Hemolysis of human erythrocytes with saponin affects the membrane structure.
Baumann E; Stoya G; Völkner A; Richter W; Lemke C; Linss W
Acta Histochem; 2000 Feb; 102(1):21-35. PubMed ID: 10726162
[TBL] [Abstract][Full Text] [Related]
7. Gelatin-based nanoparticles as DNA delivery systems: Synthesis, physicochemical and biocompatible characterization.
Morán MC; Rosell N; Ruano G; Busquets MA; Vinardell MP
Colloids Surf B Biointerfaces; 2015 Oct; 134():156-68. PubMed ID: 26188853
[TBL] [Abstract][Full Text] [Related]
8. Poly(amidoamine)s as potential endosomolytic polymers: evaluation in vitro and body distribution in normal and tumour-bearing animals.
Richardson S; Ferruti P; Duncan R
J Drug Target; 1999; 6(6):391-404. PubMed ID: 10937285
[TBL] [Abstract][Full Text] [Related]
9. Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption.
Lee CS; Park W; Park SJ; Na K
Biomaterials; 2013 Dec; 34(36):9227-36. PubMed ID: 24008035
[TBL] [Abstract][Full Text] [Related]
10. Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles.
Jones RA; Cheung CY; Black FE; Zia JK; Stayton PS; Hoffman AS; Wilson MR
Biochem J; 2003 May; 372(Pt 1):65-75. PubMed ID: 12583812
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal monitoring endocytic and cytosolic pH gradients with endosomal escaping pH-responsive micellar nanocarriers.
Hu J; Liu G; Wang C; Liu T; Zhang G; Liu S
Biomacromolecules; 2014 Nov; 15(11):4293-301. PubMed ID: 25317967
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers escaping from hyperacidified endo/lysosomes in cancer cells allow tumor-targeted intracellular delivery of antibodies to therapeutically inhibit c-MYC.
Chen P; Yang W; Hong T; Miyazaki T; Dirisala A; Kataoka K; Cabral H
Biomaterials; 2022 Sep; 288():121748. PubMed ID: 36038419
[TBL] [Abstract][Full Text] [Related]
13. A quantitative study of the intracellular fate of pH-responsive doxorubicin-polypeptide nanoparticles.
Wang J; Bhattacharyya J; Mastria E; Chilkoti A
J Control Release; 2017 Aug; 260():100-110. PubMed ID: 28576641
[TBL] [Abstract][Full Text] [Related]
14. Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.
Kilchrist KV; Dimobi SC; Jackson MA; Evans BC; Werfel TA; Dailing EA; Bedingfield SK; Kelly IB; Duvall CL
ACS Nano; 2019 Feb; 13(2):1136-1152. PubMed ID: 30629431
[TBL] [Abstract][Full Text] [Related]
15. Cytosolic delivery of macromolecules. II. Mechanistic studies with pH-sensitive morpholine lipids.
Asokan A; Cho MJ
Biochim Biophys Acta; 2003 Apr; 1611(1-2):151-60. PubMed ID: 12659956
[TBL] [Abstract][Full Text] [Related]
16. A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs.
Bulmus V; Woodward M; Lin L; Murthy N; Stayton P; Hoffman A
J Control Release; 2003 Dec; 93(2):105-20. PubMed ID: 14636717
[TBL] [Abstract][Full Text] [Related]
17. Metal-Organic Framework-Based Nanoplatform for Intracellular Environment-Responsive Endo/Lysosomal Escape and Enhanced Cancer Therapy.
Dong K; Wang Z; Zhang Y; Ren J; Qu X
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31998-32005. PubMed ID: 30178654
[TBL] [Abstract][Full Text] [Related]
18. Modeling of the endosomolytic activity of HA2-TAT peptides with red blood cells and ghosts.
Lee YJ; Johnson G; Pellois JP
Biochemistry; 2010 Sep; 49(36):7854-66. PubMed ID: 20704453
[TBL] [Abstract][Full Text] [Related]
19. Melatonin protects human red blood cells from oxidative hemolysis: new insights into the radical-scavenging activity.
Tesoriere L; D'Arpa D; Conti S; Giaccone V; Pintaudi AM; Livrea MA
J Pineal Res; 1999 Sep; 27(2):95-105. PubMed ID: 10496145
[TBL] [Abstract][Full Text] [Related]
20. Understanding the mechanism of action of poly(amidoamine)s as endosomolytic polymers: correlation of physicochemical and biological properties.
Griffiths PC; Paul A; Khayat Z; Wan KW; King SM; Grillo I; Schweins R; Ferruti P; Franchini J; Duncan R
Biomacromolecules; 2004; 5(4):1422-7. PubMed ID: 15244460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
